Elaine Chang

1.8k total citations
47 papers, 781 citations indexed

About

Elaine Chang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Elaine Chang has authored 47 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Elaine Chang's work include Cancer Genomics and Diagnostics (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Renal cell carcinoma treatment (8 papers). Elaine Chang is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Renal cell carcinoma treatment (8 papers). Elaine Chang collaborates with scholars based in United States, China and Japan. Elaine Chang's co-authors include Florence Eddins-Folensbee, John Coverdale, Richard Pazdur, Anita L. Sabichi, Yvonne H. Sada, Julia A. Beaver, Shenghui Tang, Chana Weinstock, Tuan M. Nguyen and Yutao Gong and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Elaine Chang

42 papers receiving 753 citations

Peers

Elaine Chang
Maria Olsen Netherlands
Ismael Ghanem Spain
Mee‐Hoong See Malaysia
Yi‐Ping Hung Taiwan
Margaret Barton‐Burke United States
Emma Hudson United Kingdom
Beatriz Castelo Spain
Nita K. Lee United States
Derrick J. Beech United States
Weng Ng Australia
Maria Olsen Netherlands
Elaine Chang
Citations per year, relative to Elaine Chang Elaine Chang (= 1×) peers Maria Olsen

Countries citing papers authored by Elaine Chang

Since Specialization
Citations

This map shows the geographic impact of Elaine Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elaine Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elaine Chang more than expected).

Fields of papers citing papers by Elaine Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elaine Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elaine Chang. The network helps show where Elaine Chang may publish in the future.

Co-authorship network of co-authors of Elaine Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Elaine Chang. A scholar is included among the top collaborators of Elaine Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elaine Chang. Elaine Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Heiss, Brian L., Elaine Chang, Hee‐Koung Joeng, et al.. (2025). FDA Approval Summary: Nogapendekin Alfa Inbakicept-pmln with BCG for BCG-Unresponsive Carcinoma In Situ. Clinical Cancer Research. 31(20). 4223–4229. 2 indexed citations
3.
4.
Chang, Elaine, Chi Song, Haley Gittleman, et al.. (2024). A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma. Clinical Cancer Research. 30(15). 3282–3286. 5 indexed citations
5.
Brave, Michael H., William F. Maguire, Chana Weinstock, et al.. (2024). FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Locally Advanced or Metastatic Urothelial Carcinoma. Clinical Cancer Research. 30(21). 4815–4821. 14 indexed citations
6.
7.
Maguire, William F., Daniel Lee, Chana Weinstock, et al.. (2024). FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Cisplatin-Ineligible Locally Advanced or Metastatic Urothelial Carcinoma. Clinical Cancer Research. 30(10). 2011–2016. 13 indexed citations
8.
Chang, Elaine, Haley Gittleman, Erik Bloomquist, et al.. (2023). FDA pooled analysis of overall survival according to depth of response as a continuous variable in frontline advanced immuno-oncology renal cell carcinoma trials.. Journal of Clinical Oncology. 41(16_suppl). e16532–e16532.
9.
Spira, Alexander I., Mark Stewart, Suzanne F. Jones, et al.. (2021). Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Laboratory Reference Ranges and Testing Intervals Work Group. Clinical Cancer Research. 27(9). 2416–2423. 20 indexed citations
10.
Sun, Shaoyi, Qi Jia, Sophia Lin, et al.. (2021). Identification of aryl sulfonamides as novel and potent inhibitors of NaV1.5. Bioorganic & Medicinal Chemistry Letters. 45. 128133–128133. 2 indexed citations
11.
White, Donna L., Abiodun Oluyomi, Kathryn E. Royse, et al.. (2019). Incidence of AIDS-Related Kaposi Sarcoma in All 50 United States From 2000 to 2014. JAIDS Journal of Acquired Immune Deficiency Syndromes. 81(4). 387–394. 19 indexed citations
12.
Chang, Elaine, et al.. (2018). HIV-related Refractory Hodgkin Lymphoma: A Case Report of Complete Response to Nivolumab. Clinical Lymphoma Myeloma & Leukemia. 18(2). e143–e146. 14 indexed citations
13.
Hackos, David H., Shivani Ahuja, Susmith Mukund, et al.. (2016). Structural Basis of Nav1.7 Inhibition by an Isoform-Selective Small Molecule Antagonist. Biophysical Journal. 110(3). 33a–34a. 2 indexed citations
14.
Chang, Elaine, et al.. (2014). A Spoonful of Insight Makes the Medicine Go Down. Journal of Palliative Medicine. 17(5). 621–622. 1 indexed citations
15.
Sun, Shaoyi, Zaihui Zhang, Sultan Chowdhury, et al.. (2014). Discovery of triazolone derivatives as novel, potent stearoyl-CoA desaturase-1 (SCD1) inhibitors. Bioorganic & Medicinal Chemistry. 23(3). 455–465. 10 indexed citations
16.
Chang, Elaine, Florence Eddins-Folensbee, Ben Porter, & John Coverdale. (2013). Utilization of Counseling Services at One Medical School. Southern Medical Journal. 106(8). 449–453. 9 indexed citations
17.
Chang, Elaine. (2013). The Paradox of Professionalism. Academic Medicine. 88(8). 1128–1128. 5 indexed citations
18.
Chang, Elaine, Florence Eddins-Folensbee, & John Coverdale. (2012). Survey of the Prevalence of Burnout, Stress, Depression, and the Use of Supports by Medical Students at One School. Academic Psychiatry. 36(3). 177–177. 137 indexed citations
19.
Chang, Elaine, Martha E. O’Donnell, & Abdul I. Barakat. (2007). Shear stress and 17β-estradiol modulate cerebral microvascular endothelial Na-K-Cl cotransporter and Na/H exchanger protein levels. American Journal of Physiology-Cell Physiology. 294(1). C363–C371. 18 indexed citations
20.
Nguyen, Tuan M., et al.. (1999). Idiopathic polyhydramnios and perinatal outcome. American Journal of Obstetrics and Gynecology. 181(5). 1079–1082. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Olsen Breakdown of academic impact, for papers by Ismael Ghanem Breakdown of academic impact, for papers by Mee‐Hoong See Breakdown of academic impact, for papers by Yi‐Ping Hung Breakdown of academic impact, for papers by Margaret Barton‐Burke Breakdown of academic impact, for papers by Emma Hudson Breakdown of academic impact, for papers by Beatriz Castelo Breakdown of academic impact, for papers by Nita K. Lee Breakdown of academic impact, for papers by Derrick J. Beech Breakdown of academic impact, for papers by Weng Ng
Rankless by CCL
2026